97.30MMarket Cap-2835P/E (TTM)
2.070High2.070Low125Volume2.070Open2.040Pre Close261.75Turnover3.00052wk High0.00%Turnover Ratio47.00MShares1.55052wk Low-0.73EPS TTM51.35MFloat Cap3.800Historical HighLossP/E (Static)24.81MShs Float1.550Historical Low-1EPS LYR0.00%Amplitude--Dividend TTM0.57P/B1Lot Size--Div YieldTTM
Palisades Goldcorp Ltd Stock Forum
Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical firm dedicated to developing innovative therapeutics for autoimmune, inflammatory, and fibrotic diseases, has provided an update on its collaboration with Strand Life Sciences ("Strand"), a prominent bioinformatics specialist. This partnership is focused on enhancing precision medicine for ulcerative colitis (UC)...
No comment yet